Cure Alzheimer's Fund, a nonprofit focused on funding Alzheimer's disease research, has appointed Stephanie Wasco as Executive Vice President of Marketing and Communications.

Wasco will oversee the organization's brand strategy, marketing programs and communications efforts, with a mandate to broaden awareness of Cure Alzheimer's Fund's research mission and strengthen relationships with donors and the wider public.

The appointment comes as scientific organizations increasingly face a communications challenge that extends beyond simply publishing research findings. Translating complex biomedical research into information that donors, patients, families and the general public can understand has become an important part of building institutional trust and sustaining funding.

Cure Alzheimer's Fund, also known as CureAlz, funds research focused on preventing, slowing or reversing Alzheimer's disease. The organization says its research strategy prioritizes projects with the potential for significant scientific impact.

Wasco's background spans life sciences, biomedical research, technology and nonprofit communications. Most recently, she served as Senior Vice President and Head of Communications for Advanced Markets at Biocon Biologics, where she worked within the biopharmaceutical sector.

Before Biocon Biologics, Wasco was Chief Communications Officer at The Jackson Laboratory, a biomedical research institution known for its work in genetics and genomics. She also previously served as Vice President of Corporate Communications at PerkinElmer, a company operating across life sciences and diagnostics.

Earlier roles in technology and nonprofit organizations add another dimension to her experience, giving her exposure to both commercial and mission-driven communications environments.

CureAlz CEO Meg Smith said Wasco's experience communicating complex science and building brands across life sciences, biomedical research and nonprofit organizations would support the organization's efforts to reach broader audiences.

Wasco said her focus will include supporting researchers, donors and the CureAlz team as the organization works to advance Alzheimer's research.

Why Science Communications Is Becoming a Strategic Function

Wasco's appointment reflects a broader change in how research organizations approach marketing and communications.

Biomedical organizations increasingly operate in an environment where scientific breakthroughs compete for attention across traditional media, social platforms, search engines and increasingly AI-driven information systems. Communicating research accurately while making it accessible to non-specialist audiences can influence public understanding, donor engagement and institutional reputation.

For organizations dependent on philanthropy, that communication challenge has a direct business dimension. Donors need to understand not only what research is being funded, but why a particular approach could matter and how funding translates into scientific progress.

That makes the role of marketing increasingly connected to scientific storytelling rather than conventional brand promotion.

The challenge is particularly pronounced in Alzheimer's research, where scientific findings can be complex, incremental and subject to ongoing investigation. Communications teams must explain progress without overstating what individual discoveries mean for patients.

Wasco's experience across pharmaceutical communications and biomedical research could be particularly relevant to that environment. Her previous position at Biocon Biologics placed her within a global biopharmaceutical company, while The Jackson Laboratory provided experience communicating research-driven work.

The Role of Digital Engagement

CureAlz's marketing strategy will also operate within a rapidly changing digital environment.

Search engines such as Google are increasingly incorporating AI-generated summaries into the discovery process, while platforms such as ChatGPT, Google Gemini and Microsoft Copilot are changing how audiences find and consume information.

For research nonprofits, this creates both an opportunity and a communications risk. Clear, authoritative and well-structured scientific content can help organizations establish credibility across traditional search and emerging AI-mediated discovery channels. At the same time, overly simplified messaging can remove important scientific context.

The marketing leader's role therefore increasingly sits at the intersection of brand strategy, scientific communications, digital publishing, audience engagement and reputation management.

For CureAlz, the immediate priority is likely to be building awareness around its research model while strengthening the connection between researchers, donors and the organization's broader public audience.

Market Landscape

The nonprofit and life sciences sectors are becoming increasingly dependent on sophisticated communications strategies as organizations compete for funding, research partnerships, talent and public attention.

Companies such as Biocon Biologics, PerkinElmer and research organizations such as the Jackson Laboratory operate in environments where communicating complex scientific information is central to reputation and stakeholder engagement.

Cure Alzheimer's Fund has a different operating model because its mission is focused on funding research rather than commercializing pharmaceutical products. That makes donor communications particularly important. The organization must communicate scientific opportunity and progress while maintaining appropriate distinctions between research potential and proven clinical outcomes.

Wasco's career across biopharmaceutical, biomedical research, technology and nonprofit environments gives her experience across several of those communication models.

The appointment also highlights the growing convergence between marketing and communications leadership. In science-driven organizations, brand positioning increasingly depends on the quality, credibility and accessibility of the information an organization publishes.

Strategic Outlook

The appointment of Stephanie Wasco gives CureAlz an executive with experience across multiple sectors where scientific credibility and corporate reputation intersect.

Her challenge will be to turn complex research developments into clear narratives without sacrificing scientific accuracy. That means creating communications that work for researchers and institutional stakeholders while remaining accessible to donors and the public.

As digital and AI-powered discovery channels continue to reshape how people encounter scientific information, that balance is likely to become even more important.

For Cure Alzheimer's Fund, the new marketing leadership could therefore play a role beyond conventional awareness building. It may help the organization strengthen its digital presence, explain the potential impact of research more effectively and build a more durable connection between scientific progress and donor engagement.

Top Insights

• Stephanie Wasco brings life sciences communications experience to CureAlz, strengthening the nonprofit's ability to translate complex Alzheimer's research into accessible public narratives.
• Her background at Biocon Biologics, The Jackson Laboratory and PerkinElmer gives CureAlz communications expertise spanning biopharmaceuticals, biomedical research and technology.
• The appointment reflects growing demand for science-focused marketing leaders who can balance institutional credibility, donor engagement and accessible research storytelling.
• AI-powered search is changing how audiences discover scientific information, increasing the importance of authoritative digital content for research-focused organizations and nonprofits.
• CureAlz's marketing strategy will need to connect researchers, donors and the public while communicating scientific progress without overstating potential clinical outcomes.

Get in touch with our MarTech Experts.